Pharmasyntez to build Russia's largest hormonal drugs production plant

Pharmasyntez, one of Russia’s largest drugmakers, has announced its plans to build the largest production facility for hormonal drugs in the country, that will be located in the Tyumen region, according to the company, reports The Pharma Letter’s local correspondent.

The new facility will be located on a 25,000 sq meter site and will produce 16 items of various drugs. The value of investment in the project will amount to 3 billion roubles ($45 million). The new facility will also be one of the largest in terms of output in Europe.

According to Vikram Punia, president of JSC Pharmasyntez, the current situation with hormonal drugs in Russia remains complex, as domestic production covers only 5% of local needs, with the remaining requirements being met by imports.